Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.
Pending Committee Action in House of Origin
Summary
The bill stops the Alabama Board of Pharmacy, pharmacy employers, and pharmacy benefit managers from revoking, suspending, or otherwise penalizing pharmacists who suggest or fill off‑label prescriptions. It also lets anyone buy ivermectin and hydroxychloroquine over the counter, while keeping existing rules for controlled substances and untested off‑label uses. The change aims to give pharmacists the same legal protection physicians already have.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 127 changes status, plus AI-powered summaries and stage predictions.
Sign up free